Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22,672,988
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
18,624,446
-
Shares change
-
+905,947
-
Total reported value, excl. options
-
$989,044,311
-
Value change
-
+$47,360,392
-
Put/Call ratio
-
24%
-
Number of buys
-
109
-
Number of sells
-
-56
-
Price
-
$53.09
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q3 2021
208 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q3 2021.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,624,446 shares
of 22,672,988 outstanding shares and own 82.14% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3,115,834 shares), Conestoga Capital Advisors, LLC (1,846,151 shares), VANGUARD GROUP INC (1,268,447 shares), Copeland Capital Management, LLC (1,125,087 shares), GENEVA CAPITAL MANAGEMENT LLC (896,896 shares), STATE STREET CORP (760,309 shares), DIMENSIONAL FUND ADVISORS LP (682,021 shares), Ranger Investment Management, L.P. (636,989 shares), KENNEDY CAPITAL MANAGEMENT, INC. (438,755 shares), and GEODE CAPITAL MANAGEMENT, LLC (335,504 shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.